News About: Pharm. Industry
CSO business rises again in the pharmaceutical field
CSOs(Contracts Sales Organization) have risen again.
Either mid-sized pharmaceutical companies, relatively less weaken in business marketing and product power, have actively used CSOs or each of their medical represe...
Pharmaceutical companies concealing the gift giving culture on holiday
“In principle, gifts are prohibited under the CP. I feel unsafe even as using my own money.” It is a complaint of a medical representative of a domestic mid-sized pharmaceutical company facing the Chuseok.
Thus, the ...
Roche recalled Madopar Dispersible Tab due to wrong expiration datesAs expiration dates of ‘Madopar Dispersible Tab 125mg,’ a Roche’s Parkinson’s disease treatment, have been mistakenly marked, the company has recalled the product.
According to...
|
Listed pharmaceutical companies, “Weakening in both profitability and business activities”
It was indicated that while profitability of listed pharmaceutical companies have been weakened, efficiency of their business activities have also been dropped.
According to the YakupDotCom’s(www.yakup.com) analysis ...
BMS to file for an injunction of generic sales prohibition against Dong-A STIt was known that BMS has filed for an injunction to restrict sales against infringement of patent on Dong-A ST which has already launched a generic of ‘Baraclude,’ a mega-scale...
|
Top domestic pharmaceutical companies increased 10% up in sales
As a series of unfavorable factors coincided, such as the governmental drug price restriction and the MERS crisis, weakening of domestic pharmaceutical companies’ management has been suggested, but their external form...
Expansion of all the diabetes treatments’ insurance benefits, solving doctors’ dilemmas
Although DPP-4 inhibitors, SGLT-2 inhibitors, basal insulin and GLP-1 analogues have different mechanisms, they are all used to cure diabetes.
These treatments, however, are practically included in the insurance bene...
Pfizer Korea announces the ERP todayAs starting the Early Retirement Program(ERP), Pfizer Korea is going to enter a condition of the labor-management conflict over the ERP.
According to the industry concerned on ...
|
The most domestically selling meningococcemia vaccine, ‘Menveo’ to make a fresh start in GSKThe most famous traditional vaccine company, GSK(GlaxoSmithKline), acquired product approval for ‘Menveo,’ the most domestically selling meningococcemia vaccine, from the 31st o...
|
Chong Kun Dang successful in patent challenge for AvodartAs successful in the patent challenge for the prostatic and alopecia treatment, ‘Avodart(dutasteride, GSK),’ Chong Kun Dang raised a chance to launch its follow-up drug on its o...
|
